Filing Details
- Accession Number:
- 0001437749-25-004069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-14 17:55:54
- Reporting Period:
- 2025-02-13
- Filing Date:
- 2025-02-14
- Accepted Time:
- 2025-02-14 17:55:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434647 | Zevra Therapeutics Inc. | ZVRA | Pharmaceutical Preparations (2834) | 205894398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1945557 | Joshua Schafer | C/O Zevra Therapeutics, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL 34747 | Cco & Evp, Bus. Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-13 | 10,500 | $7.86 | 29,486 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 10/15/2024
Billionaire Hedge Funds
